2017-03-23,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By Certain Officers And Directors Of Proteon Therapeutics, Inc.
2017-03-17,Proteon Therapeutics To Present At The Oppenheimer 27th Annual Healthcare Conference March 22nd
2017-03-16,Proteon Therapeutics Announces Full-Year 2016 Financial Results And Changes To The Ongoing Phase 3 PATENCY-2 Clinical Trial
2017-02-06,Proteon Therapeutics Announces Two Presentations At The American Society Of Diagnostic And Interventional Nephrology Meeting  
2017-01-05,These 5 Stocks Under $10 Could Make You a Lot of Money
2016-12-13,Proteon Therapeutics Announces Top-Line Data From Phase 3 PATENCY-1 Clinical Trial Of Investigational Vonapanitase In Patients With CKD
2016-11-10,Proteon Therapeutics Announces First Patient Dosed In Phase 1 Study Evaluating Vonapanitase For The Treatment Of Peripheral Artery Disease Below The Knee
2016-11-09,Proteon Therapeutics To Participate In Two Upcoming Investor Conferences
2016-11-07,Proteon Therapeutics Announces Third Quarter 2016 Financial Results
2016-10-25,Proteon Therapeutics Announces Overview Of Phase 1 Clinical Program Of Investigational Vonapanitase In Peripheral Artery Disease To Be Presented At The 28th Transcatheter Cardiovascular Therapeutics (TCT) Conference
2016-10-20,Proteon Therapeutics Appoints Paul Hastings Chairman Of Its Board Of Directors
2016-09-01,Proteon Therapeutics To Present At Two Upcoming Investor Conferences
2016-08-08,Proteon Therapeutics Announces Second Quarter 2016 Financial Results
2016-06-26,7 Stocks Under $10 to Trade for Big Post-Brexit Gains
2016-06-15,Proteon Therapeutics To Present At The JMP Securities Life Sciences Conference June 22nd
2016-05-09,Proteon Therapeutics Announces First Quarter 2016 Financial Results
2016-04-28,Proteon Therapeutics Announces Survey Findings Demonstrating Impact Of Vascular Access Failure On Hemodialysis Patients
2016-04-13,Proteon Therapeutics Announces Publication In The Journal Of Cardiovascular Pharmacology Of Promising Nonclinical Results For Vonapanitase In Peripheral Artery Disease
2016-03-14,Proteon Therapeutics Announces Fourth Quarter And Full-Year 2015 Financial Results
2016-03-02,Proteon Therapeutics To Present At The Cowen And Company 36th Annual Health Care Conference On March 8th
2016-02-02,Proteon Therapeutics To Present At The 2016 BIO CEO & Investor Conference February 8th
2016-01-12,RSI Alert: Proteon Therapeutics (PRTO) Now Oversold
2015-12-02,Proteon Therapeutics To Present At The Oppenheimer 26th Annual Healthcare Conference December 9th
2015-11-13,Proteon Therapeutics To Present At The Stifel 2015 Healthcare Conference On November 17th
2015-11-12,Proteon Therapeutics Announces Third Quarter 2015 Financial Results
2015-11-09,Proteon Therapeutics To Host Research And Development Day On November 20, 2015
2015-11-02,Proteon Therapeutics Completes Enrollment In PATENCY-1, First Phase 3 Clinical Study Of Investigational Vonapanitase
2015-10-28,Proteon Therapeutics To Present At The BIO-Europe 2015 Conference November 3
2015-10-19,Proteon Therapeutics Appoints Tony Kingsley To Its Board Of Directors
2015-10-12,Proteon Therapeutics Announces Results From Phase 1 Study Of Investigational Drug Vonapanitase In Patients With Symptomatic Peripheral Artery Disease Presented At TCT 2015
2015-09-02,Proteon Therapeutics To Present At Two Upcoming Investor Conferences
2015-09-01,Proteon Therapeutics Appoints Jennifer Panagoulias As Vice President Of Regulatory Affairs
2015-08-14,Proteon Therapeutics Becomes Oversold (PRTO)
2015-08-13,Proteon Therapeutics Announces Second Quarter 2015 Financial Results
2015-08-13,Proteon Therapeutics Announces Top-Line Results From Phase 1 Study Of Investigational Drug Vonapanitase In Patients With Symptomatic Peripheral Artery Disease
2015-08-12,Proteon Therapeutics Initiates Second Phase 3 Clinical Study Of Investigational Drug Vonapanitase
2015-07-22,Proteon Therapeutics Appoints Scott Canute To Its Board Of Directors
2015-06-29,Proteon Therapeutics Announces Addition To Russell 2000 Index
2015-06-17,Proteon Therapeutics To Present At The JMP Securities Life Science Conference June 24th
2015-06-02,Proteon Therapeutics Appoints Scott Toner As Senior Vice President Of Marketing
2015-05-22,Proteon Therapeutics To Present At Upcoming ERA-EDTA Annual Congress
2015-05-13,Proteon Therapeutics Announces First Quarter 2015 Financial Results
2015-04-13,Proteon Therapeutics To Present At Two International Vascular Access Conferences
2015-03-26,Proteon Therapeutics Announces Positive Long-Term Results From Phase 2 Study Of Investigational New Drug Vonapanitase In Chronic Kidney Disease Patients Undergoing Surgical Creation Of An Arteriovenous Fistula For Hemodialysis
2015-03-20,Proteon Therapeutics Announces Fourth Quarter And Full-Year 2014 Financial Results
2015-02-26,Proteon Therapeutics To Present At The Cowen And Company 35th Annual Healthcare Conference On March 4th
2015-02-06,Proteon Therapeutics To Ring The Nasdaq Stock Market Opening Bell On February 9th
2015-02-05,Proteon Therapeutics To Present At The 17th Annual BIO CEO & Investor Conference February 9th
2015-01-08,Journal Of Cardiovascular Pharmacology Publishes Positive Nonclinical Results Of Proteon Therapeutics' PRT-201 In Peripheral Artery Disease
2014-12-08,Proteon Therapeutics To Present At The Oppenheimer 25th Annual Healthcare Conference December 11th
2014-11-25,Proteon Therapeutics Announces Third Quarter 2014 Financial Results
2014-11-24,Proteon Therapeutics Announces The Closing Of Initial Public Offering And The Underwriters' Option To Purchase Additional Shares
2014-11-17,Proteon Therapeutics To Present At The Stifel Nicolaus 2014 Healthcare Conference November 18th
,
,
,
,
2017-03-23,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By Certain Officers And Directors Of Proteon Therapeutics, Inc.
2017-03-17,Proteon Therapeutics To Present At The Oppenheimer 27th Annual Healthcare Conference March 22nd
2017-03-16,Proteon Therapeutics Announces Full-Year 2016 Financial Results And Changes To The Ongoing Phase 3 PATENCY-2 Clinical Trial
2017-02-06,Proteon Therapeutics Announces Two Presentations At The American Society Of Diagnostic And Interventional Nephrology Meeting  
2017-01-05,These 5 Stocks Under $10 Could Make You a Lot of Money
2016-12-13,Proteon Therapeutics Announces Top-Line Data From Phase 3 PATENCY-1 Clinical Trial Of Investigational Vonapanitase In Patients With CKD
2016-11-10,Proteon Therapeutics Announces First Patient Dosed In Phase 1 Study Evaluating Vonapanitase For The Treatment Of Peripheral Artery Disease Below The Knee
2016-11-09,Proteon Therapeutics To Participate In Two Upcoming Investor Conferences
2016-11-07,Proteon Therapeutics Announces Third Quarter 2016 Financial Results
2016-10-25,Proteon Therapeutics Announces Overview Of Phase 1 Clinical Program Of Investigational Vonapanitase In Peripheral Artery Disease To Be Presented At The 28th Transcatheter Cardiovascular Therapeutics (TCT) Conference
2016-10-20,Proteon Therapeutics Appoints Paul Hastings Chairman Of Its Board Of Directors
2016-09-01,Proteon Therapeutics To Present At Two Upcoming Investor Conferences
2016-08-08,Proteon Therapeutics Announces Second Quarter 2016 Financial Results
2016-06-26,7 Stocks Under $10 to Trade for Big Post-Brexit Gains
2016-06-15,Proteon Therapeutics To Present At The JMP Securities Life Sciences Conference June 22nd
2016-05-09,Proteon Therapeutics Announces First Quarter 2016 Financial Results
2016-04-28,Proteon Therapeutics Announces Survey Findings Demonstrating Impact Of Vascular Access Failure On Hemodialysis Patients
2016-04-13,Proteon Therapeutics Announces Publication In The Journal Of Cardiovascular Pharmacology Of Promising Nonclinical Results For Vonapanitase In Peripheral Artery Disease
2016-03-14,Proteon Therapeutics Announces Fourth Quarter And Full-Year 2015 Financial Results
2016-03-02,Proteon Therapeutics To Present At The Cowen And Company 36th Annual Health Care Conference On March 8th
2016-02-02,Proteon Therapeutics To Present At The 2016 BIO CEO & Investor Conference February 8th
2016-01-12,RSI Alert: Proteon Therapeutics (PRTO) Now Oversold
2015-12-02,Proteon Therapeutics To Present At The Oppenheimer 26th Annual Healthcare Conference December 9th
2015-11-13,Proteon Therapeutics To Present At The Stifel 2015 Healthcare Conference On November 17th
2015-11-12,Proteon Therapeutics Announces Third Quarter 2015 Financial Results
2015-11-09,Proteon Therapeutics To Host Research And Development Day On November 20, 2015
2015-11-02,Proteon Therapeutics Completes Enrollment In PATENCY-1, First Phase 3 Clinical Study Of Investigational Vonapanitase
2015-10-28,Proteon Therapeutics To Present At The BIO-Europe 2015 Conference November 3
2015-10-19,Proteon Therapeutics Appoints Tony Kingsley To Its Board Of Directors
2015-10-12,Proteon Therapeutics Announces Results From Phase 1 Study Of Investigational Drug Vonapanitase In Patients With Symptomatic Peripheral Artery Disease Presented At TCT 2015
2015-09-02,Proteon Therapeutics To Present At Two Upcoming Investor Conferences
2015-09-01,Proteon Therapeutics Appoints Jennifer Panagoulias As Vice President Of Regulatory Affairs
2015-08-14,Proteon Therapeutics Becomes Oversold (PRTO)
2015-08-13,Proteon Therapeutics Announces Second Quarter 2015 Financial Results
2015-08-13,Proteon Therapeutics Announces Top-Line Results From Phase 1 Study Of Investigational Drug Vonapanitase In Patients With Symptomatic Peripheral Artery Disease
2015-08-12,Proteon Therapeutics Initiates Second Phase 3 Clinical Study Of Investigational Drug Vonapanitase
2015-07-22,Proteon Therapeutics Appoints Scott Canute To Its Board Of Directors
2015-06-29,Proteon Therapeutics Announces Addition To Russell 2000 Index
2015-06-17,Proteon Therapeutics To Present At The JMP Securities Life Science Conference June 24th
2015-06-02,Proteon Therapeutics Appoints Scott Toner As Senior Vice President Of Marketing
2015-05-22,Proteon Therapeutics To Present At Upcoming ERA-EDTA Annual Congress
2015-05-13,Proteon Therapeutics Announces First Quarter 2015 Financial Results
2015-04-13,Proteon Therapeutics To Present At Two International Vascular Access Conferences
2015-03-26,Proteon Therapeutics Announces Positive Long-Term Results From Phase 2 Study Of Investigational New Drug Vonapanitase In Chronic Kidney Disease Patients Undergoing Surgical Creation Of An Arteriovenous Fistula For Hemodialysis
2015-03-20,Proteon Therapeutics Announces Fourth Quarter And Full-Year 2014 Financial Results
2015-02-26,Proteon Therapeutics To Present At The Cowen And Company 35th Annual Healthcare Conference On March 4th
2015-02-06,Proteon Therapeutics To Ring The Nasdaq Stock Market Opening Bell On February 9th
2015-02-05,Proteon Therapeutics To Present At The 17th Annual BIO CEO & Investor Conference February 9th
2015-01-08,Journal Of Cardiovascular Pharmacology Publishes Positive Nonclinical Results Of Proteon Therapeutics' PRT-201 In Peripheral Artery Disease
2014-12-08,Proteon Therapeutics To Present At The Oppenheimer 25th Annual Healthcare Conference December 11th
2014-11-25,Proteon Therapeutics Announces Third Quarter 2014 Financial Results
2014-11-24,Proteon Therapeutics Announces The Closing Of Initial Public Offering And The Underwriters' Option To Purchase Additional Shares
2014-11-17,Proteon Therapeutics To Present At The Stifel Nicolaus 2014 Healthcare Conference November 18th
,
,
,
,
